Individualized management of schizophrenia
Thursday 7th July 2022, 5 PM (Central European Summer Time) Duratin 120 minutes
Negative symptoms are present in more than 50% of people with schizophrenia, have a significant impact on real-life functioning, and pose a substantial burden on the affected people and their families. This webinar will focus on: 1) psychopathological constructs currently regarded as relevant to the negative symptom dimension; 2) the distinction between primary and secondary negative symptoms and its relevance to clinical practice; 3) the main differences among current definitions of deficit schizophrenia, persistent negative symptoms, prominent negative symptoms and predominant negative symptoms; 4) recommendations for recognizing and assessing negative symptom domains with the appropriate tools. Individualised management with Dopamine partial agonists, will be discussed, with focus on their mechanism of action and important differences in activity at a range of other receptors that offer distinct pharmacological profiles at monoamine receptors which distinguishes them.
Our Faculties are:
Prof. S. Galderisi, Professor of Psychatry, University of Campania Luigi Vanvitelli. President Elect of the Italian Society for Psychopathology (SOPSI)
Prof A. Fagiolini, Professor of Psychiatry University of Siena, Siena, Italy.
Thursday 7th July 2022, 5 PM Central European Summer Time
05:00 pm – 05:07 pm: Welcome address - Prof Afzal Javed
05:07 pm – 05:15 pm: Introduction of Speakers – Prof Peter Morozov
05:15 pm – 06:00 pm: Prof S Galderisi Negative Symptoms of Schizophrenia: new concepts, diagnostic tools and their impact
06:00 pm – 06:45 pm: Prof A. Fagiolini Individualized treatment with partil agonists: where are the differences?
06:45 pm – 07:00 pm: Question and Answer
For all Enquiries please email email@example.com
Free access to the webinar. For Registration, please click here: Proceed for Registration
Participants can receive a CPD Certificate on complimentary basis (on request) after attending the Webinar.
This meetig has been supported by a financial grant, for educatinal purposes, from Gedeon Richter Plc and Recordati.p.A. The sponsor had no influence on the design and development of the programme or any associated materials.